The All India Institute of Medical Sciences [AIIMS] was designed to serve as a nucleus for nurturing excellence in all aspects of health and wellness program throughout India. AIIMS are a group of autonomous public medical institutes that have been declared by an Act of Parliament 1956 as “Institute of National Importance”. AIIMS Mangalagiri is one of the AIIMS healthcare institutes being established by the Ministry of Health & Family Welfare, Government of India under the Pradhan Mantri Swasthya Suraksha Yojna (PMSSY), INDIA
The AMR Clinical Reference Center, commissioned by the Ministry of Health, Labour and Welfare, was established in April 2017 with the goal of implementing measures based on the National Action Plan on Antimicrobial Resistance. The Center comprises three divisions: Clinical Epidemiology, Pharmacoepidemiology, Information and Education. The Clinical Epidemiology Division and the Pharmacoepidemiology Division together form a framework for public health and healthcare-associated surveillance. They accumulate and analyze data on the use of antimicrobials and on activities to promote their appropriate use. The Information and Education Division provides education and information on AMR and the appropriate use of antimicrobials to both health care professionals and the public.
“AMR Declaration Trust” – a public charitable trust – founded on the principles of the “Chennai Declaration”, aims to tackle the challenge of AMR by collaborating with various Governmental and Non-Governmental Organizations active in the field. We believe “Collaborate we win and compete we lose”. Therefore, only with collaborative work, we can successfully tackle the complex challenge of AMR.
For professionals who oppose Antimicrobial resistance, AMR Insights offers valuable information, targeted training and global networking and partnering opportunities.
AMR Insights is committed to eliminating Antimicrobial resistance because it does not accept that millions of innocent people need to die as a result of resistant bacteria and other microorganisms.
AMR Patient Alliance is established as an initiative of the IAPO P4PS Observatory in 2020 with a vision of reducing human-induced AMR. AMR Patient Alliance currently has over 100 individual and institutional members.
IAPO P4PS Observatory is established with the vision to see patients at the centre of safe, affordable and accessible healthcare, and a mission of reducing preventable harm through patient empowerment and engagement as equal partner in harm prevention and ensuring patient safety.
IAPO P4PS Observatory is aimed to serve as a single-point global platform for gathering and analysing patients’ expertise and experience that would feed into the national, regional and global policies aimed at improving patient and quality of care for patients by the patients, through identifying best practices, scalable solutions and systems leverages for improving patient safety and quality of care; and capturing and sharing structured learning for achieving safer care.
Antibiotic Research UK (www.antibioticresearch.org.uk) established as a charity in 2014, is addressing one of the biggest health challenges of our time, antibiotic-resistant infections. If the world does not act now, the number of deaths is predicted to rise to 10 million by 2050.
Our aim is to develop new antibiotic treatments, engage with the public and health care professionals (GPs, pharmacists, dentists), and to support people affected through our Patient Support Service. We change lives by supporting innovation and helping people affected by AMR, giving them hope in their fight against resistant infections.
We focus on four main areas of work:
The API (Pan-American Association of Infectious Diseases) is a scientific entity constituted as a Civil Association that brings together medical specialists in Infectious Diseases from the American countries and other professionals in related areas such as Microbiology, Virology, Mycology, Parasitology, Immunology, Epidemiology, Tropical Medicine. and others.
The Brazilian Society of Infectious Diseases (SBI) is a medical association of over 2,000 physicians and other health professionals working in the prevention, diagnosis and treatment of infectious diseases. The main objective of SBI is to promote the development, scientific exchange and defense of the Infectious Diseases community, with actions of collective interest, valuing professionals, benefiting the population and contributing to the excellence of Public Health in Brazil.
Global educators | Passionate campaigners | Trusted experts | Close collaborators | Industry leaders | Conversation starters
Founded in 1971, and with members in 135 countries around the world, the British Society for Antimicrobial Chemotherapy (BSAC) is a global educator, joining the dots between scientific researchers, medical communities and the wider public, encouraging and enabling them to pass on their knowledge to a global audience.
Our internationally renowned publications are among the foremost international journals in antimicrobial research, while our commitment to scientific excellence is reflected in our varied programme of events, training and free educational resources.
We know that better education can help prevent disease, develop more effective practice and influence international policy. Working together, we can ensure a safer world by developing new drugs, while making sure we use the ones we already have are used responsibly and protected for future generations.
The Cameroon Baptist Convention Health Services is a network of about 100 health facilities run by the Cameroon Baptist Convention, spread in 8 of 10 regions of Cameroon seeing 1 million out patients per year.
Centre for One Health Education, Research, & Development (COHERD) at IIPHG, Gujarat, India, is a pioneer center for excelling the one health education, training and advanced research with support from the IHPH, Bonn, Germany was established in April 2021. Indian Institute of Public Health Gandhinagar (IIPHG) is India’s first Public Health University. IIPHG is an example of the visionary leadership of Honorable Shri Narendra Modi (then Honorable Chief Minister of Gujarat), who laid the foundation stone and provided support for establishing the institute in 2008. The government of Gujarat and the Public Health Foundation of India (PHFI) entered an MoU in 2007 to establish IIPHG. Under the MoU, the Government of Gujarat allocated land and agreed to share a part of the project cost. IIPHG aims to strengthen the overall health system in the country through education, training, research, and advocacy/policy initiatives. IIPHG is recognized as a University under IIPHG Act 2015 of the Government of Gujarat. Its state-of-the-art green campus is spread over 50 acres of land in Gandhinagar with world-class research facilities and laboratories.
CIDRAP works to prevent illness and death from targeted infectious disease threats through research and the translation of scientific information into real-world, practical applications, policies, and solutions.